Kyowa Kirin, Ardelyx Amend Tenapanor Pact In Cardiorenal Disorders
Ardelyx Inc (NASDAQ: ARDX) has
68 Biggest Movers From Yesterday
Gainers
ECMOHO Limited (NASDAQ: MOHO) climbed 56.7% to close at $0.3650 on Wednesday after jumping 10% on Tuesday.
Jefferies Raises Price Target On This Small-Cap ‘Stand Out’ Biotech Stock
Ardelyx Inc (NASDAQ:ARDX) shares are trading higher after Jefferies upgraded shares to Buy from Hold and raised the price target…
41 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
ECMOHO Limited (NASDAQ: MOHO) jumped 67% to $0.3890 after jumping 10% on Tuesday.
Earnings Scheduled For February 28, 2022
Companies Reporting Before The Bell
• Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its fourth quarter.
Earnings Preview: Ardelyx
Ardelyx (NASDAQ:ARDX) is set to give its latest quarterly earnings report on Monday, 2022-02-28. Here's what investors need to know before the announcement.
Analysts estimate that Ardelyx will report an earnings per share (EPS) of $-0.30.
Ardelyx Shares Tick Higher Following Recent Circulation Of US Patent & Trademark Office Abstract For Co.’s ‘Compounds useful for treating gastrointestinal tract disorders’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=11,242,337.PN.&OS=PN/11,242,337&RS=PN/11,242,337
Ardelyx Shares Down ~17% This Week; Co. Collab Partner, Kyowa Kirin, On Monday Morning Announced Phase 3 Results Of Tenapanor For Hyperphosphatemia In Patients On Hemodialysis In Japan; Ardelyx Shares Appeared Unaffected
https://www.kyowakirin.com/media_center/news_releases/2021/pdf/e20211213_01.pdf